Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury
NCT03901352Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of mirogabalin in central neuropathic pain (CNP), sponsored by Daiichi Sankyo Co., Ltd.. Started Mar 2019; status: completed.
02
Drugs
mirogabalin
03
Conditions
central neuropathic pain (CNP)
Beyond the preview
Go deeper on NCT03901352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03901352.